ClinicalTrials.gov
public full text
Public Domain
First Human Dose Trial of NNC0215-0384 in Subjects With Rheumatoid Arthritis
This trial is conducted in Europe. The aim of this trial is to describe the safety and tolerability of single intravenous (i.v.) and subcutaneous (s.c.) doses of NNC0215-0384 in subjects with active rheumatoid arthritis (RA) on background methotrexate (MTX) treatment.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Efficacy of NNC0142-0002 in Subjects With Rheumatoid Arthritis (RA)#888220
- First-in-man Trial of NNC0142-0002 in Patients With Rheumatoid Arthritis#1072348
- A Study of Two Doses of MRC375 in Moderate to Severe Rheumatoid Arthritis Patients#1010623
- Efficacy and Safety Study of TAS5315 Compared With Placebo in Participants With Rheumatoid Arthritis.#873132
- ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis#979192
Record · ID 877277
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive